Filter
352
Filtered Results: 352
Text search:
National
Drug
Authority,
Uganda
Featured
Recommendations
29
New Publications
119
Language
Document type
No document type
208
Studies & Reports
75
Guidelines
35
Strategic & Response Plan
15
Manuals
9
Fact sheets
5
Situation Updates
3
Training Material
2
Countries / Regions
Uganda
68
Kenya
26
Malawi
12
Tanzania
12
Ethiopia
12
Global
11
Nigeria
9
South Africa
9
Zambia
9
Ghana
8
Rwanda
8
Congo, Democratic Republic of
8
Liberia
8
Sierra Leone
7
Africa
6
Namibia
4
Zimbabwe
3
Guinea
3
Syria
2
Iran
2
Senegal
2
Jordan
2
Sudan
2
Eswatini/ Swaziland
2
Pakistan
2
Thailand
1
Mexico
1
Lesotho
1
Benin
1
Cameroon
1
Albania
1
Laos
1
Burkina Faso
1
Morocco
1
Philippines
1
Haiti
1
Cambodia
1
Venezuela
1
Latin America and the Carribbean
1
Germany
1
Saudi Arabia
1
West and Central Africa
1
Western and Central Europe
1
Gabon
1
Tunisia
1
Lebanon
1
Sri Lanka
1
Greece
1
Georgia
1
Central African Republic
1
Botswana
1
South Sudan
1
Iraq
1
Somalia
1
India
1
Authors & Publishers
Publication Years
Category
Countries
155
Clinical Guidelines
31
Public Health
18
Women & Child Health
15
Key Resources
10
Pharmacy & Technologies
10
Capacity Building
4
Toolboxes
HIV
45
AMR
35
Mental Health
25
Pharmacy
20
TB
16
NTDs
12
Ebola & Marburg
10
Rapid Response
9
Refugee
9
COVID-19
7
Planetary Health
7
Caregiver
6
NCDs
6
Disability
4
Conflict
4
Global Health Education
3
Cholera
2
Health Financing Toolbox
2
Zika
2
Natural Hazards
1
Technical Update
HIV Treatment
July 2017
South Africa has faced many challenges over the past two decades, accomplishing profound positive changes in the social structure and government of the nation. This has not yet fully translated into better health for the population, however, particularly the poorest segment. In fact, the p...
Antimicrobial resistance (AMR) is an important public health concern shared by developed and developing countries. In developing countries the burden of infectious diseases is greater and exacerbated by limited access to, and availability and affordability of, antimicrobials required to treat infect...
2nd edition
These guidelines have been developed to provide guidance to the Ministry of Health in managing applications for registration of human pharmaceutical products in Rwanda. It was compiled by the Technical Working Group (TWG) on Medicines Evaluation and Registration (MER) of the East African Community M...
Preferred product characteristics” (PPCs) are key tools to incentivize and guide the development of urgently needed health products. The PPC published here describes the characteristics of new types of insecticide-treated nets (ITNs) to control malaria transmission in areas with insecticide-resist...
This fourth annual report monitors global progress towards the 2023 target for global elimination of industrially produced trans-fatty acids (TFA), highlighting achievements during the past year (October 2021 – September 2022). Countries are responding to the World Health Organization (WHO) call t...
Consolidated guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection
recommended
2nd edition. These guidelines provide guidance on the diagnosis of human immunodeficiency virus (HIV) infection, the use of antiretroviral (ARV) drugs for treating and preventing HIV infection and the care of people living with HIV. They are structured along the continuum of HIV testing, prevention,...
Risk Communication and Community Engagement (RCCE) is an essential part of any disease outbreak response. Risk communication in the context of an Ebola outbreak refers to real time exchange of information, opinion and advice between frontline responders and people who are faced with the threat of Eb...
This report sets out ways to make pre-hospital care and ambulance services operating in areas of armed violence safer. Written by the Norwegian Red Cross with support from the ICRC and the Mexican Red Cross, the report summarizes field experience in over 20 countries.
Accessed: 17.11.2019
The seven essential features of practice for scaling up are described with great clarity. They are practical and universal, and encourage local innovation. They include policy, funding and local management structure, as well as working with all possible partners and developing local context adaptati...
Schistosomiasis is a public health problem in tropical and subtropical regions of Africa, Asia, the Caribbean and South America. It is one of the neglected tropical diseases (NTDs) - a group of diseases and conditions that affect particularly low-income populations, worldwide.
Last year, WHO laun...
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation was to agree on the most important PPCs for drugs t...
This fourth annual report monitors global progress towards the 2023 target for global elimination of industrially produced trans-fatty acids (TFA), highlighting achievements during the past year (October 2021 – September 2022). Countries are responding to the World Health Organization (WHO) call t...
Bulletin of the World Health Organization 2007;85:637–643
Une traduction en français de ce résumé figure à la fin de l’article.
Al final del artículo se facilita una traducción al español.
الترجمة العربية لهذه الخلاصة في نهاية النص الكامل ل...
